Fulranumab
From Infogalactic: the planetary knowledge core
Jump to: navigation, search
Lua error in Module:Infobox at line 166: malformed pattern (missing ']').
Fulranumab is a human monoclonal antibody designed for the treatment of pain.[1]
Fulranumab was developed by Johnson & Johnson.
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
|
Monoclonals for bone, musculoskeletal, circulatory, and neurologic systems
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|
| Bone ("-os-", "-s(o)-") |
|
||||||||
| Musculoskeletal ("-mul-") |
|
||||||||
| Circulatory ("-c(i[r])-") |
|
||||||||
| Neurologic ("-ne(u)(r)-") |
|
||||||||
| Angiogenesis inhibitor ("-anibi-") |
|
||||||||
|
|||||||||
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Drugs that are a monoclonal antibody
- Articles without EBI source
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Johnson & Johnson
- Monoclonal antibody stubs
- Analgesic stubs
